申请人:CyDex Pharmaceuticals, Inc.
公开号:US10117951B2
公开(公告)日:2018-11-06
SAE-CD compositions are provided, along with methods of making and using the same. The SAE-CD compositions comprise a sulfoalkyl ether cyclodextrin having an absorption of less than 0.5 A.U. due to a drug-degrading agent, as determined by UV/vis spectrophotometry at a wavelength of 245 nm to 270 nm for an aqueous solution containing 300 mg of the SAE-CD composition per mL of solution in a cell having a 1 cm path length.
提供了 SAE-CD 组合物及其制造和使用方法。SAE-CD 组合物包含一种磺基烷基醚环糊精,在波长为 245 纳米至 270 纳米的波长下,对每毫升含有 300 毫克 SAE-CD 组合物的水溶液进行紫外/可见分光光度法测定,其药物降解剂吸收率小于 0.5 A.U.。